Alp, E. Et Al. 2012. Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3. Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , (Bangkok, Thailand).

Alp, E., Önen, H. İ., Yılmaz, A., Çobanoğlu, G., Gökçe, Ö., Özkan, A., ... Ekmekçi, A.(2012). Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3 . Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand

Alp, Ebru Et Al. "Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3," Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand, 2012

Alp, Ebru Et Al. "Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3." Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , Bangkok, Thailand, 2012

Alp, E. Et Al. (2012) . "Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3." Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , Bangkok, Thailand.

@conferencepaper{conferencepaper, author={Ebru Alp Et Al. }, title={Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3}, congress name={Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation}, city={Bangkok}, country={Thailand}, year={2012}}